Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

ComparIson of Strategies to PrepAre SeveRely CALCified Coronary Lesions 2

NCT: NCT05072730 · COMPLETED

NCT IDNCT05072730
StatusCOMPLETED
Start Date2022-12-01
Completion2026-05-21
SponsorDeutsches Herzzentrum Muenchen (OTHER)
First posted
Last updated

Brief Summary

The ISAR-CALC 2 trial is an investigator-initiated, prospective, randomized, multicenter, assessors-blind, open-label other clinical investigation. The objective of this trial is to investigate final angiographic minimal lumen diameter (MLD) following a strategy of super high-pressure balloon (OPN NC) versus intravascular lithotripsy (IVL) for drug-eluting stent (DES) implantation in severely calcified coronary lesions.

Frequently Asked Questions

What is ComparIson of Strategies to PrepAre SeveRely CALCified Coronary Lesions 2?

ComparIson of Strategies to PrepAre SeveRely CALCified Coronary Lesions 2 is a clinical trial registered under NCT05072730. Current status: COMPLETED.

What is the status of NCT05072730?

The current status of NCT05072730 (ComparIson of Strategies to PrepAre SeveRely CALCified Coronary Lesions 2) is: COMPLETED.

When did ComparIson of Strategies to PrepAre SeveRely CALCified Coronary Lesions 2 start?

ComparIson of Strategies to PrepAre SeveRely CALCified Coronary Lesions 2 started on 2022-12-01.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.